Skip to main content

People speaking multiple languages have better recovery after a stroke- Study suggests

Image
By Dr. Ahmed
A study conducted by American Heart Association suggests that people speaking multiple languages have better recovery from stroke than those who speak one language.
Study Highlights
  • Bilingual patients were twice as likely as those who spoke one language to have normal cognitive function after a stroke.
  • Bilingual patients performed better than single language patients on attention, information retrieval and organization.
Embargoed until 3 p.m. CT/4 p.m. ET, Thursday, Nov. 19 2015
DALLAS, Texas, Nov. 19, 2015— Bilingual patients were twice as likely as those who spoke one language to have normal cognitive functions after a stroke, in a study reported in the American Heart Association journal Stroke.
Previous research found bilingualism may delay the onset of Alzheimer’s disease.
“People tend to think of Alzheimer’s as the only cause of dementia, but they need to know that stroke is also an important cause,” said Subhash Kaul, D.M., senior investigator and developer of the stroke registry at Nizam’s Institute of Medical Sciences (NIMS) in Hyderabad, India.
In the new study, researchers reviewed the records of 608 patients in the NIMS stroke registry in 2006-13. More than half the patients were bilingual, defined in the study as speaking two or more languages. To ensure results weren’t due to bilinguals having a healthier lifestyle, researchers took into account other factors such as smoking, high blood pressure, diabetes and age. They found:
  • About 40 percent of bilingual patients had normal cognitive functions following a stroke, compared to about 20 percent of single language patients.
  • Bilinguals performed better on post-stroke tests that measured attention, and ability to retrieve and organize information.
  • Surprisingly, there was no difference between bilinguals and those who spoke one language in the likelihood of experiencing aphasia, a disorder that can cause difficulties in speaking, reading and writing, after a stroke.
“The advantage of bilingualism is that it makes people switch from one language to another, so while they inhibit one language, they have to activate another to communicate,” said Suvarna Alladi, D.M., lead author and a neurology professor at NIMS.
“The combined vocabulary of bilinguals can make it more difficult for them to find specific words. This may explain what appears to be a surprising result,” said Thomas Bak, M.D., study co-author at the University of Edinburgh in United Kingdom.
The study’s results may not be universally applicable to all bilingual people. Hyderabad is a multicultural city in which many languages are commonly spoken, including Telugu, Urdu, Hindi and English. “Constantly switching languages is a daily reality for many residents of Hyderabad,” Alladi said. “The cognitive benefit may not be seen in places where the need to function in two or more languages isn’t as extensive.”
People who speak only one language shouldn’t necessarily begin learning another one, Kaul said. “Our study suggests that intellectually stimulating activities pursued over time, from a young age or even starting in mid-life, can protect you from the damage brought on by a stroke.”
On average, someone in the United States has a stroke every 40 seconds, according to the American Heart Association’s 2015 Statistical Update.
Other co-authors are Shailaja Mekala, Ph.D.; Amulya Rajan, M.A.; Jaydip Ray Chaudhuri, D.M.; Eneida Mioshi, Ph.D.; Rajesh Krovvidi, D.M.; Bapiraju Surampudi, Ph.D. and Vasanta Duggirala, Ph.D. Author disclosures are on the manuscript.
The Indian Council of Medical Research funded the study.
Labels:

Comments

Post a Comment

Popular posts from this blog

Story of Vitamin B17/Amygdalin/Laetrile/ and Cancer

By Dr. Ahmed
Amygdalin is a compound found in seeds of all fruits except those of citrus fruits. It is found in high amounts in Apricot kernels and Almonds.  Anti-tumor properties of Amygdalin have been discussed and argued over and over through out the cancer research circles. A quick google search of 'Amygdalin' will tell you that it is a 'quack medicine', that it has no action on cancer cells and that it is dangerously poisonous substance. Laetrile is the name of semi-synthetic (drug- tablet and injection) form of amygdalin available in the market.  Let me present the readers with PubMed articles - published data in prestigious peer reviewed journals, regarding the anti-tumor properties of Amygdalin. Links will be provided with each statement. Amygdalin has anti-tumor tumor properties. It has antitussive and antiasthamatic effects. It has apoptotic effect on Renal Fibroblasts- helpful in chronic kidney disease. It stimulates the immune system and acts as an analg...
Post a Comment
Read more

Mr. Drosten's strange relationship to freedom of expression

By Dr. Ahmed
  Christian Drosten This is Christian Drosten , who is responsible for the Covid PCR protocol that bypassed the peer review process. There most likely wouldn't have been any pandemic if he hadn't committed scientific fraud. The irony is that he now appears to be advocating for the restriction of scientific freedom in favor of health policy, a notion that's completely unconstitutional. During a discussion at the "World Health Summit" in October, Drosten emphasized the rise in misinformation online, especially during the COVID-19 'pandemic', and urged media and fellow scientists to correct false information. He suggested that scientific institutions should select and spotlight individuals who are 'true experts' in their fields to combat misinformation. The concern arises as to who gets to decide who these "true experts" are. Is Drosten volunteering himself for this role? His past statements might suggest so. Drosten, in a previous interview...
Post a Comment
Read more

FDA approves experimental Genetically Modified Salmon for human consumption without Safety Trials/Studies

By Dr. Ahmed
The U.S. Food and Drug Administration (FDA) has brazenly betrayed the public's trust by approving the world's first genetically modified (GM) animal in direct defiance of science – a transgenic salmon branded "AquAdvantage" that has never been proven safe for human consumption or the natural environment. The New York Times (NYT) reports that AquAdvantage, a product of AquaBounty Technologies, has received official FDA approval after years of fierce lobbying by its manufacturer in favor of open approval. Despite repeated warnings from detractors that AquAdvantage poses serious threats to aquatic ecosystems and humans, the FDA has determined that this GM fish is completely safe for everything and everyone on the planet.  Many of the claims made about AquAdvantage by its manufacturer have been debunked, including the lie that this "Frankenfish" grows more quickly than natural salmon and is less prone to disease – both of which claims are patently false. ...
Post a Comment
Read more